In the wake of the Congress probing the recall of liquid children’s Tylenol and other pediatric medicines by a Johnson & Johnson unit, the Company proclaimed on Tuesday that it has ordered the recall of another round of drugs which have already been supplied in the market.
McNeil Consumer Healthcare, the unit of Johnson & Johnson, which is under investigation, has directed the recall of Benadryl allergy tablets and one lot of Extra Strength Tylenol gel pills.
However, the officials refused to explain anything regarding the quantity of the medicines to be recalled.
“The products were inadvertently omitted from an earlier recall one preceding the children’s drug recall involving medicines made at a company plant in Puerto Rico”, said J&J.
Since November 2009, McNeil has witnessed the recall of nearly 11.7 million packs of Motrin products and around 6.3 million bottles of Tylenol Arthritis Pain caplets.
The first recall was ordered by the company when it acknowledged complaints about rotten smell coming out of some products.
It was later discovered by the FDA that the smell was the resultant of contamination of these products with a derivative of a material used for treating wooden transport pallets.
- Shadow Health Secretary Andy Burnham talks about Ongoing Problems in NHS
- Restraint Technique on Mental Health Patients Risks Their Lives
- Antibiotics Before A year Increases Baby’s Chances of Developing Eczema by 40%
- NHS Bureaucracy Supports Secrecy Instead of Addressing Problems
- NHS Boss Dons a Superman Costume to Promote Workout